Skip to main content

IMNX News

Soon-to-be-Joined Amgen and Immunex Miss Earnings Together

Both had drugs with better-than-expected sales and blamed one-time costs for the earnings miss.

Johnson & Johnson Says Earnings Rise 12.5%, Ups Guidance

The company beats analysts' estimates, helped by strong sales of Procrit and Remicade.

Amgen, With Immunex Deal Done, Squares Off With J&J

The biotech will be dueling the big pharma over anemia drugs.

FTC Approves Amgen Acquisition of Immunex

The federal agency's OK removes the final hurdle to the $11 billion deal.

Rituxan Could Prove to Be a Double Blockbuster

Phase II results on the cancer drug show it may be very effective against rheumatoid arthritis.

Breaking News

Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests

Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.

Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat

"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.

Stocks Higher, Bank Dividends, Nike, Playtika And Occidental- Five Things To Know

Stock futures higher on global growth bets; Morgan Stanley leads bank gains after dividend boost; Nike slides as margin pressures offset Q4 earnings beat; Playtika shares surge on report of Joffre Capital interest and Occidental shares jump as Buffett adds more to stake

Walgreens Stock Slides As Group Scraps Plan to Sell UK-based Boots

"As a result of market instability ... no third party has been able to make an offer that adequately reflects the high potential value of Boots," Walgreens said.